Consolidated Statements of Income (USD $) In Millions, except Per Share data	3 Months Ended				9 Months Ended
	Sep. 30, 2011		Sep. 30, 2010		Sep. 30, 2011	Sep. 30, 2010
Revenues:
Product sales	$ 1,018.4		$ 794.3		$ 2,901.0	$ 2,276.8
Royalties	62.8		76.5		199.8	254.5
Other revenues	4.9		3.5		20.4	8.6
Total revenues	1,086.1		874.3		3,121.2	2,539.9
Costs and Expenses:
Cost of product sales	166.5	[1]	112.7	[1]	434.7	333.7
Research and development	201.5		197.9		556.3	475.9
Selling, general and administrative	452.1	[1]	392.4	[1]	1,295.3	1,106.7
Loss/(gain) on sale of product rights	0.3		0		3.8	(4.1)
Reorganization costs	5.0		9.7		18.0	23.3
Integration and acquisition costs	5.3		5.8		7.9	6.4
Total operating expenses	830.7		718.5		2,316.0	1,941.9
Operating income	255.4		155.8		805.2	598.0
Interest income	0.3		1.0		1.5	1.9
Interest expense	(9.7)		(8.3)		(28.8)	(25.6)
Other income, net	15.6		0.8		15.9	9.0
Total other income/(expense), net	6.2		(6.5)		(11.4)	(14.7)
Income before income taxes and equity in earnings/(losses) of equity method investees	261.6		149.3		793.8	583.3
Income taxes	(69.5)		(52.7)		(187.3)	(160.8)
Equity in earnings/(losses) of equity method investees, net of taxes	0.8		(0.3)		3.2	0.2
Net income	192.9		96.3		609.7	422.7
Net income attributable to Shire plc	192.9		96.3		609.7	422.7
Earning per ordinary share - basic
Earnings per ordinary share - basic	$ 0.350		$ 0.176		$ 1.106	$ 0.774
Earnings per ordinary share - diluted
Earnings per ordinary share - diluted	$ 0.339		$ 0.173		$ 1.067	$ 0.760
Weighted average number of shares (millions):
Basic	551.3		547.0		551.2	546.1
Diluted	593.8		556.7		595.0	589.7
Amounts attributable to Shire plc
Net income attributable to Shire plc	$ 192.9		$ 96.3		$ 609.7	$ 422.7

[1] Cost of product sales includes amortization of intangible assets relating to favorable manufacturing contracts of $0.5 million for the three months to September 30, 2011 (2010: $0.4 million) and $1.4 million for the nine months to September 30, 2011 (2010: $1.3 million). Research and development costs include impairment charges of $16.0 million for the three and nine months to September 30, 2011 (2010: $nil). Selling, general and administrative costs includes amortization and impairment charges of intangible assets relating to intellectual property rights acquired of $46.4 million for the three months to September 30, 2011 (2010: $73.9 million) and $119.1 million for the nine months to September 30, 2011 (2010: $142.3 million).